BIO, NVCA urge U.S. to ensure export controls won't hinder innovation

BIO has asked the U.S. Department of Commerce to consider the full impact export controls would have on the sustainability of the U.S.’s global leadership in biotech before imposing controls on specific biotechnologies. The National Venture Capital Association issued a blunter warning, saying that an overly broad definition of emerging technologies might harm innovation in the U.S.

Companies and investors in the U.S., China and elsewhere are closely watching how the government will define emerging technologies as the Committee on Foreign Investment in the United States (CFIUS) will have oversight over emerging and foundational technologies on the commerce department's export list...